0001493152-22-015263.txt : 20220527
0001493152-22-015263.hdr.sgml : 20220527
20220527103722
ACCESSION NUMBER: 0001493152-22-015263
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220304
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blosser Wendy E
CENTRAL INDEX KEY: 0001927379
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-56257
FILM NUMBER: 22973580
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA 19TH FLOOR
STREET 2: #1954
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accustem Sciences Inc.
CENTRAL INDEX KEY: 0001850767
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PENN PLAZA, 19TH FLOOR
STREET 2: #1954
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 442070661000
MAIL ADDRESS:
STREET 1: 5 PENN PLAZA, 19TH FLOOR
STREET 2: #1954
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: AccuStem Sciences Ltd
DATE OF NAME CHANGE: 20210311
3
1
ownership.xml
X0206
3
2022-03-04
0
0001850767
Accustem Sciences Inc.
ACUT
0001927379
Blosser Wendy E
5 PENN PLAZA, 19TH FLOOR, #1954
NEW YORK
NY
10001
1
1
0
0
Chief Executive Officer
Common Stock
2000
D
Options (right to buy)
2.13
2032-01-25
Common Stock
490000
D
49,000 of the options vest on January 25, 2023, 2024 and 2025 and 98,000 vest on January 25, 2026. 122,500 options vest upon the closing of a single equity raise netting not less than $30m for the Company; and 122,500 options vest upon the opening of a commercial CLIA lab in the U.S. no later than the fourth quarter 2023.
/s/ Wendy Blosser
2022-05-27